Cingulate terminates grant agreement for CTx-2103; no funds received

Cingulate Inc.

Terminated Grant Agreement with private family foundation on May 13, 2025, originally signed April 8, 2025.
No grant funds were received; no repayment or refund obligation to the foundation.
All prospective royalty and other commercialization obligations for CTx-2103 have been terminated.
Company expects to continue CTx-2103 development in 3Q 2026 after potential launch of lead asset CTx-1301.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.